A citation-based method for searching scientific literature

Christina Therkildsen, Lars Henrik Jensen, Maria Rasmussen, Inge Bernstein. Clin Exp Gastroenterol 2021
Times Cited: 5







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
40

Mismatch Repair Universal Screening of Endometrial Cancers (MUSE) in a Canadian Cohort.
Jessica Lawrence, Lara Richer, Jocelyne Arseneau, Xing Zeng, George Chong, Evan Weber, William Foulkes, Laura Palma. Curr Oncol 2021
1
100


Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
Anne M Mills, Sofia Liou, James M Ford, Jonathan S Berek, Reetesh K Pai, Teri A Longacre. Am J Surg Pathol 2014
148
20

Milestones of Lynch syndrome: 1895-2015.
Henry T Lynch, Carrie L Snyder, Trudy G Shaw, Christopher D Heinen, Megan P Hitchins. Nat Rev Cancer 2015
381
20

Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Fedaa Najdawi, Ashley Crook, Jayne Maidens, Christopher McEvoy, Andrew Fellowes, Justine Pickett, Musei Ho, David Nevell, Kirsten McIlroy, Amy Sheen,[...]. Pathology 2017
27
20

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.
Floor J Backes, Marino E Leon, Iouri Ivanov, Adrian Suarez, Wendy L Frankel, Heather Hampel, Jeffrey M Fowler, Larry J Copeland, David M O'Malley, David E Cohn. Gynecol Oncol 2009
60
20

Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
Janice S Kwon, Charlotte C Sun, Susan K Peterson, Kristin G White, Molly S Daniels, Stephanie G Boyd-Rogers, Karen H Lu. Cancer 2008
65
20

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium.
Teri A Longacre, Russell Broaddus, Linus T Chuang, Michael B Cohen, Elke A Jarboe, George L Mutter, Christopher N Otis, Richard J Zaino. Arch Pathol Lab Med 2017
11
20

Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Joseph T Rabban, Sarah M Calkins, Anthony N Karnezis, James P Grenert, Amie Blanco, Beth Crawford, Lee-May Chen. Am J Surg Pathol 2014
40
20

Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
Emad A Rakha, Nirav Gandhi, Fina Climent, Carolien H M van Deurzen, Syeda Asma Haider, Louisa Dunk, Andrew H S Lee, Douglas Macmillan, Ian O Ellis. Am J Surg Pathol 2011
72
20

Universal Testing to Identify Lynch Syndrome Among Women With Newly Diagnosed Endometrial Carcinoma.
Anna Cameron, Helene Chiarella-Redfern, Pamela Chu, Renee Perrier, Máire A Duggan. J Obstet Gynaecol Can 2020
3
33


Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Karen H Lu, John O Schorge, Kerry J Rodabaugh, Molly S Daniels, Charlotte C Sun, Pamela T Soliman, Kristin G White, Rajyalakshmi Luthra, David M Gershenson, Russell R Broaddus. J Clin Oncol 2007
178
20

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
Daniel D Buchanan, Yen Y Tan, Michael D Walsh, Mark Clendenning, Alexander M Metcalf, Kaltin Ferguson, Sven T Arnold, Bryony A Thompson, Felicity A Lose, Michael T Parsons,[...]. J Clin Oncol 2014
137
20

Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing.
Sarah E Ferguson, Melyssa Aronson, Aaron Pollett, Lua R Eiriksson, Amit M Oza, Steven Gallinger, Jordan Lerner-Ellis, Zahra Alvandi, Marcus Q Bernardini, Helen J MacKay,[...]. Cancer 2014
79
20


Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Robert A Soslow, Carmen Tornos, Kay J Park, Anais Malpica, Xavier Matias-Guiu, Esther Oliva, Vinita Parkash, Joseph Carlson, W Glenn McCluggage, C Blake Gilks. Int J Gynecol Pathol 2019
95
20


Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Laura C Collins, Victor P Carlo, Harry Hwang, Todd S Barry, Allen M Gown, Stuart J Schnitt. Am J Surg Pathol 2006
112
20

Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years.
Celine H M Leenen, Margot G F van Lier, Helena C van Doorn, Monique E van Leerdam, Sjarlot G Kooi, Judith de Waard, Robert F Hoedemaeker, Ans M W van den Ouweland, Sanne M Hulspas, Hendrikus J Dubbink,[...]. Gynecol Oncol 2012
93
20

Hormonal therapy of endometrial cancer.
Maurie Markman. Eur J Cancer 2005
41
20

Evolutionary dynamics of microsatellite DNA.
C Schlötterer. Chromosoma 2000
359
20

Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity.
Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Massimo Aglietta, Sofia Genta, Giorgio Valabrega. Oncotarget 2017
50
20

A Review of Immune Checkpoint Blockade Therapy in Endometrial Cancer.
Angela K Green, Jacqueline Feinberg, Vicky Makker. Am Soc Clin Oncol Educ Book 2020
34
20


Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.
Eric A Reits, James W Hodge, Carla A Herberts, Tom A Groothuis, Mala Chakraborty, Elizabeth K Wansley, Kevin Camphausen, Rosalie M Luiten, Arnold H de Ru, Joost Neijssen,[...]. J Exp Med 2006
20

Current Systemic Treatment Landscape of Advanced Gynecologic Malignancies.
Kathy Pan, Jun Gong, Karen Huynh, Mihaela Cristea. Target Oncol 2019
6
20


Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
711
20

Classification of endometrial carcinoma: more than two types.
Rajmohan Murali, Robert A Soslow, Britta Weigelt. Lancet Oncol 2014
322
20

Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis.
David A Barrington, Sarah E Dilley, Haller J Smith, J Michael Straughn. Gynecol Oncol 2019
14
20

Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?
Lucia Musacchio, Serena Maria Boccia, Giuseppe Caruso, Giusi Santangelo, Margherita Fischetti, Federica Tomao, Giorgia Perniola, Innocenza Palaia, Ludovico Muzii, Sandro Pignata,[...]. J Clin Med 2020
17
20

Programmed Death-Ligand 1 Expression in Muscle-Invasive Bladder Cancer Cystectomy Specimens and Lymph Node Metastasis: A Reliable Treatment Selection Biomarker?
Deborah Mukherji, Mark N Jabbour, Maya Saroufim, Sally Temraz, Rami Nasr, Maya Charafeddine, Rita Assi, Ali Shamseddine, Ayman N Tawil. Clin Genitourin Cancer 2016
32
20


Complete Remission Following Pembrolizumab in a Woman with Mismatch Repair-Deficient Endometrial Cancer and a Germline BRCA1 Mutation.
Don S Dizon, Dora Dias-Santagata, Amy Bregar, Laura Sullivan, Jennifer Filipi, Elizabeth DiTavi, Lucy Miller, Leif Ellisen, Michael Birrer, Marcela DelCarmen. Oncologist 2018
7
20

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.
Suzanne L Topalian, Mario Sznol, David F McDermott, Harriet M Kluger, Richard D Carvajal, William H Sharfman, Julie R Brahmer, Donald P Lawrence, Michael B Atkins, John D Powderly,[...]. J Clin Oncol 2014
20

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, Wen-Jen Hwu, Suzanne L Topalian, Patrick Hwu, Charles G Drake, Luis H Camacho, John Kauh, Kunle Odunsi,[...]. N Engl J Med 2012
20

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.
Janis M Taube, Robert A Anders, Geoffrey D Young, Haiying Xu, Rajni Sharma, Tracee L McMiller, Shuming Chen, Alison P Klein, Drew M Pardoll, Suzanne L Topalian,[...]. Sci Transl Med 2012
20

Optimizing immunotherapy for gynecologic cancers.
Maria M Rubinstein, Vicky Makker. Curr Opin Obstet Gynecol 2020
13
20

Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types.
Feng Wang, Qi Zhao, Ying-Nan Wang, Ying Jin, Ming-Ming He, Ze-Xian Liu, Rui-Hua Xu. JAMA Oncol 2019
140
20

A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
Kelsey T Danley, Karen Schmitz, Ritu Ghai, Joy S Sclamberg, Lela E Buckingham, Kelly Burgess, Timothy M Kuzel, Lydia Usha. Oncologist 2021
2
50

Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients.
Stefania Bellone, Floriana Centritto, Jonathan Black, Carlton Schwab, Diana English, Emiliano Cocco, Salvatore Lopez, Elena Bonazzoli, Federica Predolini, Francesca Ferrari,[...]. Gynecol Oncol 2015
53
20

Immunotherapy: New Strategies for the Treatment of Gynecologic Malignancies.
Ariel Bulua Bourla, Dmitriy Zamarin. Oncology (Williston Park) 2016
17
20

Endometrial cancer: Molecular markers and management of advanced stage disease.
Rebecca C Arend, Bayley A Jones, Alba Martinez, Paul Goodfellow. Gynecol Oncol 2018
80
20

Current recommendations and recent progress in endometrial cancer.
Rebecca A Brooks, Gini F Fleming, Ricardo R Lastra, Nita K Lee, John W Moroney, Christina H Son, Ken Tatebe, Jennifer L Veneris. CA Cancer J Clin 2019
150
20

A panoply of errors: polymerase proofreading domain mutations in cancer.
Emily Rayner, Inge C van Gool, Claire Palles, Stephen E Kearsey, Tjalling Bosse, Ian Tomlinson, David N Church. Nat Rev Cancer 2016
198
20

Real-World Experience with Pembrolizumab Treatment in Patients with Heavily Treated Recurrent Gynecologic Malignancies.
Min Chul Choi, Yong Wha Moon, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Gwangil Kim, Kyoung Ah Kim. Yonsei Med J 2020
2
50


Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.